Geron (GERN) Invested Capital (2017 - 2024)
Geron (GERN) posted Invested Capital of $71.6 million for Q3 2024, up 52.53% sequentially from $46.9 million in Q2 2024, and up 224.4% YoY from $22.1 million in Q4 2023.
Geron (GERN) Invested Capital (2017 - 2024) Analysis & Trends
Geron has reported Invested Capital for 4 years, with the latest figure at $71.6 million in Q3 2024.
- Quarterly Invested Capital rose 224.4% year-over-year to $71.6 million in Q3 2024, while the trailing twelve-month figure through Jun 2025 was $71.6 million (down 61.81% YoY) and the FY2023 annual result came in at $46.9 million, up 123.89% from the prior year.
- Invested Capital rose to $71.6 million in Q3 2024 per GERN's latest filing, from $46.9 million in the prior quarter.
- Over five years, Invested Capital peaked at $71.6 million in Q3 2024 and troughed at $5.2 million in Q2 2022.
- A 3-year average of $34.3 million and a median of $22.1 million in 2023 frame the typical range for Invested Capital.
- The sharpest annual moves came in 2023 and 2024: Invested Capital surged 70.23% in 2023, then jumped 332.73% in 2024.
- Over 3 years, Invested Capital stood at $20.9 million in 2022, then jumped by 123.89% to $46.9 million in 2023, then soared by 52.61% to $71.6 million in 2024.
- According to Business Quant data, Invested Capital over the past three periods registered $71.6 million, $46.9 million, and $71.5 million for Q3 2024, Q2 2024, and Q1 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 37.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 190.90 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 1.45 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 380.00 Mn |
| 10 | Geron | 1.02 Mn | -299.83 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 71.56 Mn |
| Jun 30, 2024 | 46.92 Mn |
| Mar 31, 2024 | 71.53 Mn |
| Dec 31, 2023 | 46.89 Mn |
| Sep 30, 2023 | 22.06 Mn |
| Jun 30, 2023 | 10.84 Mn |
| Dec 31, 2022 | 20.95 Mn |
| Sep 30, 2022 | 12.96 Mn |
| Jun 30, 2022 | 5.16 Mn |
| Jun 30, 2017 | 6.25 Mn |
| Mar 31, 2017 | 6.25 Mn |